Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

NCT02132884 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
1
Enrollment
OTHER
Sponsor class

Stopped Feasibility

Conditions

Interventions

Sponsor

Fox Chase Cancer Center

Collaborators